By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Johnson & Johnson 

1 Johnson & Johnson Plaza

New Brunswick  New Jersey  08933  U.S.A.
Phone: 732-524-0400 Fax: 732-524-3300




Alliance Pharmaceutical Corp.  Oxygent ™ co-development

Medarex, Inc.  Broad HuMAb-Mouse antibody development agreement.

Incyte Corporation 

Genetronics, Inc.  On October 6, 1998 Genetronics entered into comprehensive development and license agreements involving its proprietary drug delivery system for Electroporation Therapy treatment of cancer with Ethicon, Inc., a Johnson & Johnson company

Essential Therapeutics, Inc.   Cephalosporin which is currently in pre-clinical stages - and will target Staphylococcal infections, Enterococcal infections, and Streptococcus pneumoniae infections.

Pharmagene Laboratories Limited 

Bristol-Myers Squibb Company 

Amersham Biosciences 

PanVera LLC 

Rigel Pharmaceuticals, Inc. 

Massachusetts Life Sciences Center 

Company News
Applied Molecular Transport Announces Research And Development Collaboration With Janssen Biotech Inc. (JNJ) And Johnson & Johnson (JNJ) Innovation For Novel Therapeutic Candidate To Treat Inflammatory Bowel Diseases 1/28/2015 8:19:40 AM
Hidden Spy Camera Discovered in Johnson & Johnson (JNJ) Bathroom, Say Police 1/26/2015 8:57:52 AM
Johnson & Johnson (JNJ) Can't Prove Phone Solicitations Tainted Mesh Suit 1/23/2015 7:05:20 AM
Johnson & Johnson (JNJ) Claims It's Owed $7.2 Billion by Boston Scientific Corporation (BSX) Over Failed Guidant Corporation (GDT) Merger 1/22/2015 5:59:19 AM
Johnson & Johnson (JNJ) Release: Dr. Paul Janssen Award For Biomedical Research Issues 2015 Call For Nominations 1/21/2015 11:09:26 AM
Johnson & Johnson (JNJ) Opens Up Data From Diagnostics, Medical Device Clinical Trials 1/21/2015 6:44:52 AM
Johnson & Johnson (JNJ), Takeda (TKPYY) Open Up Israeli Biotech Incubator to Develop New Cures for Old Ills 1/21/2015 6:28:20 AM
Johnson & Johnson (JNJ) Reports 2014 Fourth-Quarter And Full-Year Results 1/20/2015 6:57:01 AM
Johnson & Johnson (JNJ) Lands $115 Million to Speed Up Development of Ebola Vaccine 1/16/2015 6:12:37 AM
Depomed, Inc. (DEPO) Smacks Down $1.05 Billion for Johnson & Johnson (JNJ)'s Pain Drug Franchise 1/15/2015 4:11:10 PM